SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Guenard G.) "

Search: WFRF:(Guenard G.)

  • Result 1-3 of 3
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Couch, Fergus J., et al. (author)
  • AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A consortium of investigators of modifiers of BRCA1/2 study
  • 2007
  • In: Cancer Epidemiology Biomarkers & Prevention. - 1538-7755. ; 16:7, s. 1416-1421
  • Journal article (peer-reviewed)abstract
    • The AURKA oncogene is associated with abnormal chromosome segregation and aneuploidy and predisposition to cancer. Amplification of AURKA has been detected at higher frequency in tumors from BRCA1 and BRCA2 mutation carriers than in sporadic breast tumors, suggesting that overexpression of AURKA and inactivation of BRCA1 and BRCA2 cooperate during tumor development and progression. The F31I polymorphism in AURKA has been associated with breast cancer risk in the homozygous state in prior studies. We evaluated whether the AURKA F31I polymorphism modifies breast cancer risk in BRCA1 and BRCA2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2. Consortium of Investigators of Modifiers of BRCA1/2 was established to provide sufficient statistical power through increased numbers of mutation carriers to identify polymorphisms that act as modifiers of cancer risk and can refine breast cancer risk estimates in BRCA1 and BRCA2 mutation carriers. A total of 4,935 BRCA1 and 2,241 BRCA2 mutation carriers and 11 individuals carrying both BRCA1 and BRCA2 mutations was genotyped for F31I. Overall, homozygosity for the 311 allele was not significantly associated with breast cancer risk in BRCA1 and BRCA2 carriers combined [hazard ratio (HR), 0.91; 95% confidence interval (95% CI), 0.77-1.061. Similarly, no significant association was seen in BRCA1 (HR, 0.90; 95% Cl, 0.75-1.08) or BRCA2 carriers (HR, 0.93; 95% CI, 0.67-1.29) or when assessing the modifying effects of either bilateral prophylactic oophorectomy or menopausal status of BRCA1 and BRCA2 carriers. In summary, the F31I polymorphism in AURKA is not associated with a modified risk of breast cancer in BRCA1 and BRCA2 carriers.
  •  
2.
  • Guenard, G., et al. (author)
  • An experimental study of the multiple effects of brown trout Salmo trutta on the bioenergetics of two Arctic charr Salvelinus alpinus morphs
  • 2012
  • In: Journal of Fish Biology. - : Wiley. - 0022-1112 .- 1095-8649. ; 81:4, s. 1248-1270
  • Journal article (peer-reviewed)abstract
    • This study investigated the importance of competition with brown trout Salmo trutta as a driver of the morphological and behavioural divergence of two morphs of Arctic charr Salvelinus alpinus. The morphs originated from two lakes differing in absence or presence of the competitor. The bioenergetics and behaviour of S. alpinus were quantified in replicate experimental enclosures (mean volume: 150 m(3)) stocked with 15 S. alpinus of one morph or the other and in the absence or presence of nine S. trutta. The presence of S. trutta decreased growth rate, affected food consumption and increased activity costs in S. alpinus, but provided little support for the hypothesis that competition with S. trutta is a major driver of the divergence of the two S. alpinus morphs. Both morphs responded similarly in terms of mean growth and consumption rates per enclosure, but the association between individual morphology and growth rate reversed between allopatric and sympatric enclosures. While the activity patterns of the two morphs were unaffected by the presence of S. trutta, their swimming speed and activity rate differed. Since the profound differences in the structure of the physical habitat of the source lakes provided a more likely explanation for the difference observed among these two morphs than interspecific competition, it is hypothesized that physical habitat may sometimes be a significant driving force of the phenotypic divergence.
  •  
3.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-3 of 3

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view